UniQuest logo

UniQuest

Oceania, Queensland, Australia, Brisbane

Description

UniQuest is a university commercializing and technology transfer company.

Investor Profile

UniQuest has backed more than 3 startups, with 2 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B, Seed rounds (top funding stages).
  • Majority of deals are located in United Kingdom, Australia.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series C (33%)
  • Series B (33%)
  • Seed (33%)

Country Focus

  • United Kingdom (67%)
  • Australia (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Recycling
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does UniQuest frequently co-invest with?

venBio Partners
North America, California, United States, San Francisco
Co-Investments: 1
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 1
Uniseed
Oceania, Queensland, Australia, Brisbane
Co-Investments: 1
Medicxi
Europe, England, United Kingdom, London
Co-Investments: 1
AV
North America, New York, United States, New York
Co-Investments: 1
TCG Crossover
North America, California, United States, Palo Alto
Co-Investments: 1
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 1
Co-Investments: 1
GBS Ventures
Oceania, Victoria, Australia, Melbourne
Co-Investments: 1
Brandon Capital
Oceania, Victoria, Australia, Melbourne
Co-Investments: 1

What are some of recent deals done by UniQuest?

Earthodic

Brisbane, Queensland, Australia

Earthodic is an Australian materials science business makes useful biobased coatings.

BiotechnologyRecycling
SeedOct 29, 2024
Amount Raised: $3,934,973
Vicebio

London, England, United Kingdom

Vicebio is committed to employing the Molecular Clamp Technology to create vaccines against next-generation respiratory viruses.

BiotechnologyMedical
Series BSep 23, 2024
Amount Raised: $100,000,000
Spinifex Pharmaceuticals

Preston, Lancashire, United Kingdom

Spinifex Pharmaceuticals is a clinical-stage biotechnology company specializing in the development of products for the treatment of pain.

BiotechnologyHealth CarePharmaceutical
Series CApr 10, 2014
Amount Raised: $45,000,000